Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 19788383)

1.

Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease.

Guerrero DM, Perez F, Conger NG, Solomkin JS, Adams MD, Rather PN, Bonomo RA.

Surg Infect (Larchmt). 2010 Feb;11(1):49-57. doi: 10.1089/sur.2009.022. Review.

2.

Acinetobacter baumannii skin and soft-tissue infection associated with war trauma.

Sebeny PJ, Riddle MS, Petersen K.

Clin Infect Dis. 2008 Aug 15;47(4):444-9. doi: 10.1086/590568. Review.

3.

Treatment of Acinetobacter infections.

Michalopoulos A, Falagas ME.

Expert Opin Pharmacother. 2010 Apr;11(5):779-88. doi: 10.1517/14656561003596350. Review.

PMID:
20210684
4.

Insights into acinetobacter war-wound infections, biofilms, and control.

Dallo SF, Weitao T.

Adv Skin Wound Care. 2010 Apr;23(4):169-74. doi: 10.1097/01.ASW.0000363527.08501.a3. Review.

PMID:
20299843
5.

Skin and soft-tissue infections caused by Aeromonas species.

Chao CM, Lai CC, Tang HJ, Ko WC, Hsueh PR.

Eur J Clin Microbiol Infect Dis. 2013 Apr;32(4):543-7. doi: 10.1007/s10096-012-1771-y. Epub 2012 Nov 8.

PMID:
23135756
6.

Severe soft tissue infections.

Napolitano LM.

Infect Dis Clin North Am. 2009 Sep;23(3):571-91. doi: 10.1016/j.idc.2009.04.006. Review.

PMID:
19665084
7.

Mortality associated with Pandrug-resistant Acinetobacter baumannii infections in Thailand.

Apisarnthanarak A, Mundy LM.

Am J Infect Control. 2009 Aug;37(6):519-20. doi: 10.1016/j.ajic.2008.10.024. No abstract available.

PMID:
19643284
8.

Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1063-6.

9.

[Infections caused by Acinetobacter spp. in critically ill ICU patients].

Alvarez-Lerma F, Palomar M, Insausti J, Olaechea P, Cerdá E, Castillo F, Martínez-Pellús A; Grupo de Estudio Nacional de Vigilancia de Infección Nosocomial en UCI.

Enferm Infecc Microbiol Clin. 2005 Nov;23(9):533-9. Spanish.

PMID:
16324565
10.

[Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].

Celik IH, Demirel G, Tatar Aksoy H, Saygan S, Canpolat FE, Uras N, Oğuz SS, Erdeve O, Dilmen U.

Mikrobiyol Bul. 2011 Oct;45(4):716-22. Turkish.

PMID:
22090302
11.

Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment.

Cisneros JM, Rodríguez-Baño J.

Clin Microbiol Infect. 2002 Nov;8(11):687-93. Review.

12.

Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.

Mihu MR, Martinez LR.

Virulence. 2011 Mar-Apr;2(2):97-102. Epub 2011 Mar 1. Review.

13.

Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006.

Wadl M, Heckenbach K, Noll I, Ziesing S, Pfister W, Beer J, Schubert S, Eckmanns T.

Infection. 2010 Feb;38(1):47-51. doi: 10.1007/s15010-009-9225-x. Epub 2010 Jan 27.

PMID:
20108161
14.

Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.

Anunnatsiri S, Tonsawan P.

Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703.

PMID:
21706949
15.

An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.

Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, Fishbain J, Craft D, Riddell S, Lindler L, Mancuso J, Milstrey E, Bautista CT, Patel J, Ewell A, Hamilton T, Gaddy C, Tenney M, Christopher G, Petersen K, Endy T, Petruccelli B.

Clin Infect Dis. 2007 Jun 15;44(12):1577-84. Epub 2007 May 8.

16.

Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.

Beavers SF, Blossom DB, Wiemken TL, Kawaoka KY, Wong A, Goss L, McCormick MI, Thoroughman D, Srinivasan A.

Public Health Rep. 2009 Nov-Dec;124(6):868-74.

17.

Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan.

Chang PY, Hsueh PR, Wu PS, Chan PC, Yang TT, Lu CY, Chang LY, Chen JM, Lee PI, Lee CY, Huang LM.

J Microbiol Immunol Infect. 2007 Oct;40(5):406-10.

PMID:
17932600
18.

Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.

Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO.

J Hosp Infect. 2009 Jul;72(3):234-42. doi: 10.1016/j.jhin.2009.03.023. Epub 2009 Jun 3.

PMID:
19493588
19.

Acinetobacter baumannii emerging as a multidrug-resistant skin and soft-tissue pathogen: parallels to methicillin-resistant Staphylococcus aureus.

Adler BL, Krausz A, Friedman AJ.

JAMA Dermatol. 2014 Aug;150(8):905-6. doi: 10.1001/jamadermatol.2013.8855. No abstract available.

PMID:
24943071
20.

Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.

Moon SY, Peck KR, Chang HH, Kim SW, Heo ST, Son JS, Ryu SY, Moon C, Jung SI, Shin SY, Lee JA, Joung MK, Chung DR, Kang CI, Song JH.

Microb Drug Resist. 2012 Dec;18(6):562-6. doi: 10.1089/mdr.2012.0010. Epub 2012 Jul 9.

PMID:
22775562
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk